Liberia
IAVI vaccinates first participants in Phase I Lassa fever vaccine trial
The trial will assess the safety, tolerability, and potential of the vaccine to induce an immune response against Lassa fever.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox